A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Intention |
---|---|
Submitter | Norway |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Remarks | Cooperation with Denmark. |
Classification
Proposed harmonised classification by the dossier submitter |
|
---|
Intention timeline
Date of intention | 2019-11-08 |
---|---|
Expected date of submission | 2020-06-08 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
June 15, 2020
- Harmonised classification at the time of the proposal: Aquatic Acute 1, H400
- Harmonised classification at the time of the proposal: Aquatic Chronic 1, H410
- Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, H400
- Proposed harmonised classification by the dossier submitter: Aquatic Chronic 1, H410
- Status: Intention → Submitted
- Submitted for accordance check: 2020-06-05
Nov. 30, 2020
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/371efcfd-578c-b482-eb23-9e350d550435
- CLH report: https://echa.europa.eu/documents/10162/2d0f0808-c1b3-b418-8962-b431d0ebd54d
- Deadline for commenting: 2021-01-29
- Final submission date: 2020-09-18
- Hazard classes open for commenting: Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure
- Legal deadline for opinion adoption: 2022-03-20
- Status: Submitted → Consultation
- Start of consultation: 2020-11-16
Feb. 15, 2021
- Comments received: https://echa.europa.eu/documents/10162/12f92490-cd4e-7bbe-30f5-0a204c84f72a
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/9831fb75-4c6f-6da3-7fef-10936715e702
- Status: Consultation → Opinion Development
March 27, 2021
- Name: 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol → 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol;tetrabromobisphenol-A
April 9, 2021
- Name: 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol;tetrabromobisphenol-A → 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol
Oct. 8, 2021
- Date of opinion: 2021-09-16
- Status: Opinion Development → Opinion Adopted
Jan. 6, 2022
- Background document: https://echa.europa.eu/documents/10162/a784e1a0-558f-7f0a-ad00-7cb457f04693
- Comments received: https://echa.europa.eu/documents/10162/12f92490-cd4e-7bbe-30f5-0a204c84f72a → https://echa.europa.eu/documents/10162/ec6d02f7-6724-02c9-91e5-ea7beade2b31
- RAC opinion: https://echa.europa.eu/documents/10162/4d29288d-d6a5-4aa0-f3a2-40741237c2b6
This version
June 3, 2020
- Expected date of submission: 2020-06-01 → 2020-06-08
Add the related substance to your watchlist to monitor this regulatory record.